摘要
目的探究高血压脑出血术后使用低分子肝素预防形成下肢深静脉血栓的效果。方法选择于2016年5月—2017年5月进入该院实行手术治疗的102例高血压脑出血患者为研究主体对象,利用随机数字表法将所有患者划分为对照组及观察组,每组51例;对照组患者实行常规治疗,观察组患者实行低分子肝素治疗,对比2组患者的治疗有效率及并发症发生率。结果经治疗,对照组与观察组治疗有效率分别为78.43%及96.08%二者相比差异有统计学意义(P<0.05);经治疗,对照组与观察组并发症发生率分别为15.69%及1.96%二者相比差异有统计学意义(P<0.05)。结论高血压脑出血患者术后实行适量低分子肝素治疗的效果良好,能有效预防形成下肢深静脉血栓降低并发症发生率,值得在临床治疗中使用及推广。
Objective to explore the effect of low molecular weight heparin on prevention of deep vein thrombosis after hypertensive intracerebral hemorrhage. Methods 102 cases of hypertensive intracerebral hemorrhage were selected from May 2016 to May 2017, and the subjects were divided into control group and observation group, 51 cases were divided into control group and observation group, and the control group was treated with routine treatment, and the patients in the observation group were treated with low molecular weight heparin, and the treatment of low molecular weight heparin was carried out in the observation group. The effective rate and incidence of complications were compared between the 2 groups. Results after treatment, the difference between the control group and the observation group was 78.43% and96.08% two respectively, and the 2 groups had the difference was statistically significant(P<0.05). After treatment, the incidence of complications in the control group and the observation group was 15.69% and 1.96% two, respectively, and the 2 groups had statistical significance(P 0.05). Conclusion the effect of low molecular weight heparin(LMWH) in patients with hypertensive intracerebral hemorrhage is good, and it can effectively prevent the incidence of lower extremity deep venous thrombosis, which should be used and popularized in clinical treatment.
作者
夏传星
XIA Chuan-xing(Feixian County Medical Center Health Center Shandong Linyi 273401)
出处
《双足与保健》
2018年第16期15-16,共2页
Biped and Health
关键词
高血压脑出血
低分子肝素
下肢深静脉血栓
Hypertensive cerebral hemorrhage
Low molecular weight heparin
Deep venous thrombosis of lower extremity
